SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-002017
Filing Date
2020-02-12
Accepted
2020-02-12 09:20:22
Documents
3
Period of Report
2020-02-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 30001
2 ex99-1.htm EX-99.1 45600
3 ex99-1_001.jpg GRAPHIC 3496
  Complete submission text file 0001493152-20-002017.txt   81754
Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452
Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947
RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16467 | Film No.: 20600454
SIC: 2834 Pharmaceutical Preparations